LifeAire Systems Welcomes Bob Hicks as President & COO

LifeAire Systems today announced the addition of Robert (Bob) Hicks as President and Chief Operating Officer.

Bob brings a 30-year track record of success in business operations, sales, marketing, and executive leadership helping a wide range of companies from entrepreneurial startups to multi-million-dollar national firms.

“We are very pleased to welcome Bob to the LifeAire team,” said CEO & Founder, Dr. Kathryn C. Worrilow. “He has been part of the extended LifeAire ecosystem for many years and has recently begun contributing to our partnership and market growth strategies. His experience and insight come at a critical point for LifeAire as we’re experiencing a strong reception from hospitals, IVF programs, long term care facilities, with our air purification solutions both domestically and internationally. With Bob’s guidance and considerable experience, we look forward to transforming LifeAire and extending our reach further into the global healthcare community to enable healthcare professionals everywhere to provide top quality care in environments free from airborne pathogens.”

“I have known LifeAire’s founder for several years and have continually been impressed with the company’s products, culture, and customer centric philosophies,” said Bob Hicks. “I am excited and thrilled to be joining both a great team and company delivering such a critical solution where it’s needed most.”

LifeAire Systems, LLC is an innovative healthcare technology company that develops, manufactures, and commercializes air filtration systems for an array of industries, including: healthcare, in-vitro fertilization, life sciences, long term care, dental, education, entertainment, commercial, hospitality, and transportation. LifeAire’s patented, multi-stage purification system remediates up to 99.99% of biological and chemical contaminants in both source and return air in a single pass, which minimizes human exposure to harmful airborne contaminants and maximizes safety for everyone downstream of the system. From the outset, LifeAire was designed to handle the most difficult airborne contaminants, namely the anthrax spore, which enables its technologies to easily kill or inactivate COVID-19 (Coronavirus), tuberculosis, pneumonia, and influenza. For this reason, LifeAire is the chosen solution by the world’s leading healthcare institutions and medical centers, including: Stanford University, Northwestern, University of California San Francisco (UCSF), University of Connecticut, Mayo Clinic, University of Massachusetts, Wake Forest University, Yale University, St. Luke’s University Health Network, and other leading healthcare providers. Where LifeAire has been installed, it has consistently delivered significant improvement in key operational metrics and clinical outcomes.